| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Buying > Invisible Home Buyers Impacting Housing Markets and Trends |
|
Top Adding - Invisible Home Buyers Impacting Housing Markets and Trends
One story not portrayed in residential real estate market reports are the growing ranks of home buyers who c According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product an't afford to purchase a home, even if they wanted to. I predicted in mid-2004 that these invisible first-t ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ime buyers, whose presence is not reported in housing statistics could have a slowing effect on future home lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. sales, at all levels. The invisible buyer while out of sight, should not be out of mind. These off-the-rada here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe housing consumers pose large implications for all in the housing market. Without first-time buyers, those t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hat want to sell to move-up or move-on, can’t. According to a March 2007 nationwide poll conducted by Bankra ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc te.com, affordability is the number one reason that is restraining renters from purchasing a home. With hom easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e appreciation far out pacing growth of personal incomes, Nearly forty-percent of first-time home buyers in nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically he Bankrate.com poll said that they simply can't afford today's home prices. Many would be first-time home b and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ uyers have waited on the sidelines in the boom years as prices went up, up, and up, while their annual salar ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi y increases merely kept up with inflation. Now, faced with even higher prices, they feel that owning the Ame ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rican dream is out of reach. Real estate is a food chain, take one component out and it ripples through the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod market. Even upper-bracket home sellers aren't immune from the basic first-time, entry level home buyer. If cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin the first-timer can't enter the market to buy, then the move-up buyers who want to sell and purchase a more tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen desirable home can't. Eventually with the move-up's stalled in neutral, even those desiring to make the fin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel al move-up into the upper bracket home of their dreams are in a holding pattern as well. What's will be the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust result of this affordability gap? An increase in lease-to-own real estate contracts, shrinkage in the size o y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products f new homes ( as I predicted in my 2006 annual survey "What's In, What's Out with Homebuyers"), and an incre . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ase in multiple household ownership of single-family properties. I also see first-time home buyers relocatin elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip g to markets where housing is more affordable at entry levels. Copyright 2007 All Rights Reserved. Mark Nas tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Technologies Impact on Medical Device Clean Rooms Top Google Adwords Strategies Revealed Tips on Getting A Good Deal on Low Interest Debt Consolidation Loans
|